drugset / Trial / NCT00780650
Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine
Phase 0
Completed
56 enrolled
University of Maryland, Baltimore
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedCrossoverDouble-blindTreatment
Summary
This study is aimed at determining if the drug Atomoxetine (Strattera-used to treat Attention Deficit Hyperactivity Disorder(ADHD) has effects on the body's ability to defend itself against low blood sugar.
Timeline
- Start
- 2009-05
- Primary completion
- 2018-08-21
- Completion
- 2018-08-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atomoxetine | Other / unclassified | 80 mg | Oral |